Directed Selling. Such Non-U.S. Note Holder has not engaged, nor is it aware that any party has engaged, and such Non-U.S. Note Holder will not engage or cause any third party to engage, in any directed selling efforts (as such term is defined in Regulation S) in the United States with respect to the Note Conversion Shares.
Appears in 3 contracts
Sources: Note Conversion Agreement (GT Biopharma, Inc.), Note Conversion Agreement (Oxis International Inc), Note Conversion Agreement (Oxis International Inc)